Wild type and mutants of the HET-s(218-289) prion show different flexibility at fibrillar ends: a simulation study

Ran Friedman1, Amedeo Caflisch

  • 1Department of Chemistry and Biomedical Sciences, Linnaeus University, 391 82, Kalmar, Sweden; Linnaeus University, Center for Biomaterials Chemistry, 391 82, Kalmar, Sweden; Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland.

Proteins
|September 17, 2013
PubMed

Insights

Molecular dynamics simulations reveal that mutations in the HET-s prion protein reduce flexibility at fibril ends. This finding explains directional fibril growth and loss of prion infectivity in mutants.

Area of Science:

  • Structural biology
  • Biophysics
  • Mycology

Background:

  • The HET-s protein from Podosporina anserina contains a prion-forming domain (residues 218-289).
  • Amyloid fibrils formed by HET-s(218-289) adopt a β solenoid structure.
  • Mutants Phe286Ala and Trp287Ala exhibit reduced in vitro aggregation and loss of prion infectivity.

Purpose of the Study:

  • To compare the flexibility of HET-s prion protein mutants (Phe286Ala, Trp287Ala) with the wild type using molecular dynamics.
  • To provide an atomistic explanation for the role of flexibility in HET-s amyloid fibril elongation and directional growth.

Main Methods:

  • Molecular dynamics (MD) simulations initiated from a trimeric aggregate.
  • Simulations were performed on a 100-ns timescale.
  • Analysis of atomic fluctuations, interaction energy, and buried accessible surface area.

Main Results:

  • Both wild-type and mutant HET-s(218-289) aggregates remained structurally stable over 100 ns.
  • Mutants showed reduced flexibility in the C-terminal segment of external monomers.
  • Phe286 was found to be stabilized in the Trp287Ala mutant, impacting flexibility.

Conclusions:

  • Flexibility at the ends of HET-s amyloid protofibrils is crucial for fibril elongation.
  • The study provides atomistic insights supporting directional growth of HET-s amyloid fibrils.
  • Reduced flexibility in mutants correlates with impaired prion infectivity.